CAS: 1441000-45-8
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide REF: 3D-RHC00045CAS: 1441000-45-8 | Min. 95% | Prezzo su richiesta | Mer 22 Gen 25 |
 | Opiranserin REF: TM-T16399CAS: 1441000-45-8 | 98% | 907,00 €~2.337,00 € | Mer 29 Gen 25 |
![4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide](https://static.cymitquimica.com/products/3D/thumb/RHC00045.jpg)
4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide
CAS:1441000-45-8
4-Butoxy-N-[4-(dimethylamino)oxan-4-yl]methyl]-3,5-dimethoxybenzamide (BDMOB) is a molecule that has been shown to act as a serotonin receptor …
Formula:
C21H34N2O5
Purezza:
Min. 95%
Peso molecolare:
394.5 g/mol
Ref: 3D-RHC00045
| 25mg | 229,00 € | ||
| 250mg | 912,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 22 Gennaio 2025
Opiranserin
CAS:1441000-45-8
Opiranserin is a development as an injectable agent for the treatment of postoperative pain.
Formula:
C21H34N2O5
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
394.51
- Inibitori
- Neuroscienza
- recettore 5-HT
- GlyT
- Vedere altre categorie
- Proteina G/GPCR
Ref: TM-T16399
| 25mg | 1.410,00 € | ||
| 50mg | 1.851,00 € | ||
| 100mg | 2.337,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 29 Gennaio 2025
